Endothelin-1-induced vasoconstriction in humans: reversal by calcium channel blockade but not by nitrovasodilators or endotheliumderived relaxing factor Circulation 1991;83:469–475 65 Sakurai T, Yanagisawa M, Takuwa Y, et al Cloning of a cDNA encoding a non-isopeptideselective subtype of the endothelin receptor Nature 1990;348:732–735 66 Wamhoff BR, Bowles DK, Owens GK Excitation-transcription coupling in arterial smooth muscle Circ Res 2006;98:868–878 67 Owens GK, Kumar MS, Wamhoff BR Molecular regulation of vascular smooth muscle cell differentiation in development and disease Physiol Rev 2004;84:767–801 68 Somlyo AV, Somlyo AP Intracellular signaling in vascular smooth muscle Adv Exp Med Biol 1993;346:31–38 69 Woodrum DA, Brophy CM The paradox of smooth muscle physiology Mol Cell Endocrinol 2001;177:135–143 70 Brozovich FV, Nicholson CJ, Degen CV, et al Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders Pharmacol Rev 2016;68:476–532 71 Kim HR, Appel S, Vetterkind S, et al Smooth muscle signalling pathways in health and disease J Cell Mol Med 2008;12:2165–2180 72 Iyemere VP, Proudfoot D, Weissberg PL, et al Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification J Intern Med 2006;260:192–210 73 Shanahan CM, Weissberg PL Smooth muscle cell phenotypes in atherosclerotic lesions Curr Opin Lipidol 1999;10:507–513 74 Tyson KL, Reynolds JL, McNair R, et al Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification Arterioscler Thromb Vasc Biol 2003;23:489– 494 75 Davies JD, Carpenter KL, Challis IR, et al Adipocytic differentiation and liver x receptor pathways regulate the accumulation of triacylglycerols in human vascular smooth muscle cells J Biol Chem 2005;280:3911–3919 76 Tintut Y, Alfonso Z, Saini T, et al Multilineage potential of cells from the artery wall Circulation 2003;108:2505–2510 77 King KE, Iyemere VP, Weissberg PL, et al Kruppell-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor beta 1 in the regulation of vascular smooth muscle cell phenotype J Biol Chem 2003;278:11661– 11669 78 Stegemann JP, Hong H, Nerem RM Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype J Appl Physiol 2005;98:2321–2327 79 Berne RM Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow Am J Physiol 1963;204:317–322 80 Bayliss WM On the local reactions of the arterial wall to changes in internal pressure J Physiol 1902;28:220–231 81 Hill MA, Davis MJ, Meininger GA, et al Arteriolar myogenic signaling mechanisms: implications for local vascular function Clin Hemorheol Microcirc 2006;34:67–79 82 Joannides R, Haefeli WE, Linder L, et al Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo Circulation 1995;91:1314–1319 83 Cooke JP, Rossitch E Jr, Andon NA, et al Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator J Clin Invest 1991;88:1663–1671 84 Miura H, Wachtel RE, Liu Y, et al Flow-induced